Development of carrier-free nanodrugs based on low molecular weight heparin–doxorubicin conjugate assembly with smart pH-triggered drug release characteristics for combinatorial antitumor therapy-Reference-Cited by-同舟云学术

Development of carrier-free nanodrugs based on low molecular weight heparin–doxorubicin conjugate assembly with smart pH-triggered drug release characteristics for combinatorial antitumor therapy

Published:2022 Issue:2 Volume:46 Page:820-831
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Fan Bo¹²^ORCID,Li Qian¹,Jiang Yanping¹,Shen Weiguang¹,Xing Yang¹,Liang Guixian¹,Wu Qian¹,Ban Shurong¹,Zhang Ruiping²^ORCID

Affiliation:

1. Department of Pharmacy, Shanxi Medical University, Taiyuan, 030001, Shanxi, People's Republic of China

2. The Radiology Department of Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Tongji Medical College, Huazhong University of Science and Technology, Taiyuan, 030032, China

Abstract

A LMWH–DOX nanodrug effectively released bioactive agents, providing a combination therapy of low molecular weight heparin and doxorubicin for angiogenesis suppression and carcinoma inhibition.

Funder

Shanxi Province Science Foundation for Youths

National Natural Science Foundation of China

Shanxi Scholarship Council of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2022/NJ/D1NJ04224F

Reference33 articles.

1. Tumor angiogenesis: causes, consequences, challenges and opportunities

2. Angiogenesis as a hallmark of solid tumors - clinical perspectives

3. Tumor angiogenesis: molecular pathways and therapeutic targets

4. Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis

5. Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advance Progress in Assembly Mechanisms of Carrier-Free Nanodrugs for Cancer Treatment;Molecules;2023-10-13